| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Envoy Medical, Inc. | Chief Financial Officer | Stock Option (right to buy) | 293,250 | 15 Oct 2023 | Direct | ||
| HeartSciences Inc. | Director | Stock Option (Right to Buy) | 25,000 | 09 Jul 2025 | Direct | ||
| HeartSciences Inc. | Director | Restricted Stock Units | 15,000 | 12 Jan 2026 | Direct | ||
| HeartSciences Inc. | Director | Employee Stock Option (Right to Buy) | 6,000 | 16 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HSCS | HeartSciences Inc. | 12 Jan 2026 | 1 | $0 | 4 | Director | 12 Jan 2026, 20:03 |
| HSCS | HeartSciences Inc. | 09 Jul 2025 | 1 | $0 | 4 | Director | 11 Jul 2025, 21:00 |
| HSCS | HeartSciences Inc. | 16 Jan 2025 | 1 | $0 | 4 | Director | 21 Jan 2025, 17:17 |
| COCH | Envoy Medical, Inc. | 15 Oct 2023 | 1 | $0 | 4 | Chief Financial Officer | 17 Oct 2023, 16:09 |
| COCH | Envoy Medical, Inc. | 29 Sep 2023 | 0 | $0 | 3 | Chief Financial Officer | 29 Sep 2023, 21:03 |
| HSCS | Heart Test Laboratories, Inc. | 20 Mar 2023 | 1 | $0 | 4 | Director | 22 Mar 2023, 19:56 |
| HSCS | Heart Test Laboratories, Inc. | 28 Dec 2022 | 0 | $0 | 3 | Director | 06 Jan 2023, 16:50 |